NEWS

Media

07

February | 2017

Cannabics Pharmaceuticals Announces Initial Commercialization of Cannabinoids-based Personalized Diagnostics for Cancer Patients

BETHESDA, Maryland, Feb. 6, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) today announced it will begin providing personalized can

03

January | 2017

Cannabics Pharmaceuticals Announces a New Dosage of 5mg THC Cannabis Capsule Treating Cancer Patients Suffering from Cachexia and Anorexia Syndrome

BETHESDA, Maryland, Jan. 3, 2017 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced development of Cannabics 5mg THC Capsule intend

01

December | 2016

OTC Markets Group Welcomes Newly Verified OTCQB Companies

OTC Markets Group Inc.(OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today announced the following companies are ve

01

December | 2016

Cannabics Pharmaceuticals Announces Specific Ratios of Cannabinoids Led to Apoptosis in MDA-MB-231 Breast Cancer Cell Viability

BETHESDA, Maryland, Dec. 1, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) announced today that results from the company's Cancer HTS rese

06

June | 2016

Cannabics Pharmaceuticals has Filed a PCT Application, Covering a Novel Personalized Anti-Cancer Diagnostics System

BETHESDA, Maryland, June 6, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) filed a PCT Application with the US Patent & Trademark Offi

22

March | 2016

Cannabics Pharmaceuticals Announces Start of Clinical Study in Israel for Cancer Patients

BETHESDA, Maryland, March 22, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) today announced the start of a clinical study in Israel for can

29

February | 2016

Cannabics Pharmaceuticals Places IP & Subsidiary Within the Company

BETHESDA, Maryland, Feb. 29, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) announced that it has placed its wholly owned subsidiary "Grin

24

February | 2016

Cannabics Pharmaceuticals Files Patent Application for the Company’s Slow Release Capsules

BETHESDA, Md., Feb. 24, 2016 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (CNBX) announced today that it has filed an exclusive provisional patent a

09

October | 2015

Cannabics Pharmaceuticals Inc. Announces a New Division of Labor in the Corporate Structure

BETHESDA, Maryland, October 9, 2015 Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) has announced its execution of an Intellectual Property &

08

September | 2015

Cannabics Pharmaceuticals Inc. Announces New Access of Cannabics Oil Capsules for Patients With Medical Cannabis License in Israel

BETHESDA, Md., Sept. 8, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that Israeli patients with a medical cannabi

11

August | 2015

OTC Markets Group Welcomes Newly Verified OTCQB Companies

OTC MARKETS GROUP INC.(OTCQX: OTCM), OPERATOR OF OPEN, TRANSPARENT AND CONNECTED FINANCIAL MARKETS, TODAY ANNOUNCED THE FOLLOWING COMPANIES ARE VERIFIED

03

August | 2015

Cannabics Pharmaceuticals Inc. Announces Increasing Sales of WanaCapsXR Capsules in Every Region of Colorado

BETHESDA, Maryland, Aug. 13, 2015 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) announced today that first reports from Colorado show t

21

October | 2013

Revocation of BCSC Cease Trade Order

Revocation Order American Mining Corporation Section 171 of the Securities Act, R.S.B.C. 1996, c. 418 1 On August 26, 2011, the Executive

26

August | 2011

British Columbia Securities Commission – Cease Trade Order

2011 BCSECCOM 409 Cease Trade Order American Mining Corporation Section 164 of the Securities Act, R.S.B.C. 1996, c. 418 1 American Mining